Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GENETIC TECHNOLOGIES LIMITED Board/Management Information 2003

Aug 17, 2003

65022_rns_2003-08-17_c0f8339b-4f05-40b2-b80d-baf959abe944.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

18 August 2003

The Manager Company Announcements Office Australian Stock Exchange Limited Exchange Centre 20 Bridge Street Sydney NSW 2000

Dear Sir.

Appointment of Director of Science - Dr Adrian Hodgson

GTG is pleased to announce it has appointed Dr Adrian Hodgson, as its new Director of Science.

Dr Hodgson gained his B.Sc. (Hons) and later his PhD at La Trobe University in Melbourne. He has also worked at University of Tennessee and Monash University, and in the R&D division at CSL Limited. After 11 years at CSIRO, the last 5 years as Manager of a multi-disciplinary team developing new vaccines and bio-therapeutics for livestock, he was appointed CEO of Vectogen, which licensed in technology from CSIRO.

Dr Hodgson has published widely in international journals and is experienced in the prosecution of patents and the negotiation of commercial licenses. In 2002, Dr. Hodgson was awarded a CSIRO team medal for science innovation and commercialisation. He is also a Fellow of the Australian Society for Microbiology.

In addition, GTG is now establishing a Scientific Advisory Committee under the direction of Professor Deon Venter, and further announcements will be made shortly, as appropriate.

Yours faithfully,

Dr Mervyn Jacobson Executive Chairman